Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-10T03:50:15.327Z Has data issue: false hasContentIssue false
  • English
  • Français

Rationale against Preoperative Screening for HIV in Polish Hospitals: A Prevalence Study of Anti-HIV in Contrast to Anti-Hepatitis C Virus and Hepatitis B Surface Antigen

Published online by Cambridge University Press:  02 January 2015

Maria Gańczak  and
Zbigniew Szych
Maria Gańczak*
Affiliation:
Department of Hygiene, Epidemiology, and Public Health, Pomeranian Medical University, Szczecin, Poland
Zbigniew Szych
Affiliation:
Department of Computer Science and Education Quality Research, Pomeranian Medical University, Szczecin, Poland
*
Department of Hygiene, Epidemiology, and Public Health, Pomeranian Medical University, Zolnierska 48, 70-210 Szczecin, Poland (ganczak2@wp.pl)
Get access Rights & Permissions [Opens in a new window]

Abstract

We describe the prevalence of anti-human immunodeficiency virus (anti-HIV) among a sample of 1,652 surgical and gynecologic patients in Polish hospitals, contrasting it with the prevalence of hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (anti-HCV) to assess the rationale for preoperative testing. No anti-HIV-positive samples were found; the prevalence of anti-HCV was 0.9%, slightly higher than the prevalence of HBsAg of 0.6%. Universal preoperative screening of hospital patients for HIV is currently not warranted according to the Centers for Disease Control and Prevention guidelines. However, the seroprevalence of HIV should be reassessed periodically.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 12 , December 2009 , pp. 1227 - 1229
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Branson, B. Current HIV epidemiology and revised recommendations for HIV testing in health-care settings. J Med Virol 2007;79(Suppl 1): S6–S10.Google Scholar
2.Branson, BM, Handsfield, HH, Lampe, MA, et al.CDC revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55:1–17.Google ScholarPubMed
3.Weiss, ES, Cornwell, EE III, Wang, T, et al.HIV and hepatitis testing and prevalence among surgical patients in an urban university hospital. Am J Surg 2007;193:55–60.CrossRefGoogle Scholar
4.Dresing, K, Pouwels, C, Bonsack, S, et al.HCV, HBV and HIV infections: risk for surgeon and staff—results and consequences of routine screening in emergency patients [in German]. Chirurg 2003;74:1026–1033.Google Scholar
5.Wanyenze, RK, Navawu, C, Namale, AS, et al.Acceptability of routine HIV counseling and testing, and HIV seroprevalence in Ugandan hospitals. Bull World Health Organ 2008;86:302–309.Google Scholar
6.Gańczak, M, Barss, P. Fear of HIV infection and impact of training on the attitudes of surgical and emergency nurses toward inpatient HIV testing. Infect Control Hosp Epidemiol 2007;28:230–233.CrossRefGoogle ScholarPubMed
7.UNAIDS. AIDS epidemic update 2007. Geneva, Switzerland: UNAIDS. Updated November 26, 2007. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2()07/default.asp. Accessed lune 1, 2009.Google Scholar
8.Gańczak, M, Szych, Z. Infections with HBV, HCV and HIV in patients admitted to the neurosurgical department of a teaching hospital. Neurol Neurochir Pol 2008;42:231–237.Google Scholar
9.Gostin, LO. HIV screening in health care settings: public health and civil liberties in conflict? JAMA 2006;296:2023–2025.Google Scholar
10.Nitka, A, Rosihska, M, Janiec, J. AIDS and HIV infection in Poland [in Polish], Przegl Epidemiol 2008;62:357–368.Google ScholarPubMed
11.Ankiersztejn-Bartczak, M. Anonymous and free of charge HIV testing: experience of counseling and testing center in Warsaw [in Polish]. Kontra 2007;2:1–3.Google Scholar
12.Holtgrave, R. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing. PLoS Med 2007;4:e194. http://www.plosmedicine.Org/article/info:doi/10.1371/journal.pmed.0040194. Accessed June 1, 2009.CrossRefGoogle ScholarPubMed
13.Vermund, SH, Wilson, CM. Barriers for HIV testing. Lancer 2002;360:1186–1187.Google Scholar